Michiel Zwaan - STERIS Plc Chief Human Resource Officer, Vice President
| STE Stock | USD 199.01 2.20 1.09% |
President
Mr. Michiel de Zwaan is Chief Human Resource Officer, Vice President of the Company. He assumed this role in September 2017. He served as Senior Vice President and Chief Human Resources Officer at HillRom Inc. from August 2014 through December 2015, and as Vice President of Human Resources, International, at HillRom Europe B.V. from September 2011 through July 2014. since 2017.
| Age | 45 |
| Tenure | 7 years |
| Address | 70 Sir John Rogerson?s Quay, Dublin, Ireland, D02 R296 |
| Phone | 353 1 232 2000 |
| Web | https://www.steris.com |
STERIS Plc Management Efficiency
The company has Return on Asset of 0.0477 % which means that on every $100 spent on assets, it made $0.0477 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0911 %, implying that it generated $0.0911 on every 100 dollars invested. STERIS Plc's management efficiency ratios could be used to measure how well STERIS Plc manages its routine affairs as well as how well it operates its assets and liabilities. As of April 17, 2024, Return On Tangible Assets is expected to decline to 0.02. In addition to that, Return On Capital Employed is expected to decline to 0.03. At present, STERIS Plc's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 216.5 M, whereas Debt To Assets are forecasted to decline to 0.16.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| David Lassiter | National HealthCare | 59 | |
| Michael Ussery | National HealthCare | 65 | |
| R Ussery | National HealthCare | 60 | |
| Peter Mantegazza | Encompass Health Corp | N/A | |
| Brian Wayment | Pennant Group | N/A | |
| Leroy McIntosh | National HealthCare | 63 | |
| Donald Daniel | National HealthCare | 67 | |
| Brian Kidd | National HealthCare | 49 | |
| Frank Brown | Encompass Health Corp | N/A | |
| Jeffrey Smith | National HealthCare | 61 | |
| Thomas Mullin | Select Medical Holdings | 40 | |
| Jerry Gray | Encompass Health Corp | N/A | |
| Kevin Reese | The Ensign Group | N/A | |
| Gerald Coggin | National HealthCare | 62 | |
| Julia Powell | National HealthCare | 68 | |
| B Flatt | National HealthCare | 57 | |
| Barbara Jacobsmeyer | Encompass Health Corp | 55 | |
| Scott Romberger | Select Medical Holdings | 63 | |
| Josh McCreary | National HealthCare | 51 | |
| Linda Wilder | Encompass Health Corp | N/A | |
| Robert Breighner | Select Medical Holdings | 55 | |
Management Performance
| Return On Equity | 0.0911 | ||||
| Return On Asset | 0.0477 |
STERIS plc Leadership Team
Elected by the shareholders, the STERIS Plc's board of directors comprises two types of representatives: STERIS Plc inside directors who are chosen from within the company, and outside directors, selected externally and held independent of STERIS. The board's role is to monitor STERIS Plc's management team and ensure that shareholders' interests are well served. STERIS Plc's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, STERIS Plc's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Richard Breeden, Independent Director | ||
| Daniel Carestio, Chief Operating Officer, Senior Vice President, Director | ||
| John Wareham, Independent Chairman of the Board | ||
| J Zangerle, Senior Vice President General Counsel, Secretary | ||
| Julia Madsen, Senior Sciences | ||
| Kevin McMullen, Independent Director | ||
| Gulam Khan, Senior Vice President - Procedural Solutions | ||
| Michael Wood, Independent Director | ||
| Andrew Xilas, Senior Dental | ||
| Julie Winter, Vice Communications | ||
| Jack Wareham, Independent Chairman of the Board | ||
| Michael Tokich, CFO, Principal Accounting Officer, Sr. VP and Treasurer | ||
| Karen Burton, CFO, Chief Accounting Officer, Vice President Controller | ||
| Paul Martin, Independent Director | ||
| John Zangerle, Senior Vice President General Counsel, Secretary | ||
| Michiel Zwaan, Chief Human Resource Officer, Vice President | ||
| Kenneth Kohler, Senior AST | ||
| Adrian Coward, Senior Vice President - Healthcare Specialty Services | ||
| Jacqueline Kosecoff, Independent Director | ||
| Mary Fraser, SVP Officer | ||
| Cynthia Feldmann, Independent Director | ||
| Renato Tamaro, Vice President and Corporate Treasurer | ||
| Nirav Shah, Independent Director | ||
| Mohsen Sohi, Independent Chairman of the Board | ||
| Adam Zangerle, Company Secretary | ||
| Walter Rosebrough, CEO and President Director and Member of Compliance Committee | ||
| Richard Steeves, Independent Director | ||
| Loyal Wilson, Independent Director | ||
| Duncan Nichol, Independent Director | ||
| Christopher Holland, Independent Director | ||
| Bruce Edwards, Director | ||
| Kathleen Bardwell, COO, Senior Vice President | ||
| Sudhir Pahwa, Senior Vice President - Infection Prevention Technologies | ||
| David Lewis, Independent Director | ||
| Cary Majors, Vice President - North America Commercial Operations |
STERIS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is STERIS Plc a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0911 | ||||
| Return On Asset | 0.0477 | ||||
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 23.21 B | ||||
| Shares Outstanding | 98.81 M | ||||
| Shares Owned By Insiders | 0.27 % | ||||
| Shares Owned By Institutions | 97.96 % | ||||
| Number Of Shares Shorted | 2.68 M | ||||
| Price To Earning | 36.93 X |
STERIS Plc Investors Sentiment
The influence of STERIS Plc's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in STERIS. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to STERIS Plc's public news can be used to forecast risks associated with an investment in STERIS. The trend in average sentiment can be used to explain how an investor holding STERIS can time the market purely based on public headlines and social activities around STERIS plc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
STERIS Plc's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for STERIS Plc's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average STERIS Plc's news discussions. The higher the estimated score, the more favorable is the investor's outlook on STERIS Plc.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards STERIS Plc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, STERIS Plc's short interest history, or implied volatility extrapolated from STERIS Plc options trading.
Currently Active Assets on Macroaxis
| LTC | Litecoin | |
| STETH | Staked Ether | |
| LINK | Chainlink | |
| XLM | Stellar | |
| CRO | Cronos |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in STERIS plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate. For information on how to trade STERIS Stock refer to our How to Trade STERIS Stock guide.You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for STERIS Stock analysis
When running STERIS Plc's price analysis, check to measure STERIS Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy STERIS Plc is operating at the current time. Most of STERIS Plc's value examination focuses on studying past and present price action to predict the probability of STERIS Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move STERIS Plc's price. Additionally, you may evaluate how the addition of STERIS Plc to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is STERIS Plc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of STERIS Plc. If investors know STERIS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about STERIS Plc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.145 | Dividend Share 1.98 | Earnings Share 5.69 | Revenue Per Share 54.709 | Quarterly Revenue Growth 0.148 |
The market value of STERIS plc is measured differently than its book value, which is the value of STERIS that is recorded on the company's balance sheet. Investors also form their own opinion of STERIS Plc's value that differs from its market value or its book value, called intrinsic value, which is STERIS Plc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because STERIS Plc's market value can be influenced by many factors that don't directly affect STERIS Plc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between STERIS Plc's value and its price as these two are different measures arrived at by different means. Investors typically determine if STERIS Plc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, STERIS Plc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.